Monoamine oxidase inhibitors (MAOIs) are used primarily in the treatment of schizophrenia.

Monoamine Oxidase Inhibitors (MAOIs)

A class of antidepressant drugs that work by inhibiting the activity of monoamine oxidase, thereby increasing the levels of certain neurotransmitters in the brain.

Schizophrenia

Schizophrenia is a chronic mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior.